Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-09-27 00:00:00 ET · period of report 2023-09-26 · accession 0001517026-23-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-27 | 2023-09-26 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $15.99 | -3,523 | 258.1K | -1% | -$56.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-26 | F | D | 3,523 | $15.99 | 258,105 | D | — | — |